Michael J.
Fox’s foundation has launched a $2.5-billion fundraising campaign aimed at accelerating new Parkinson’s treatments and research toward a cure.
The Michael J.
Fox Foundation for Parkinson’s Research announced the multi-year initiative, called “All Grit.
No Quit.,” on September 17, 2026.
The foundation said more than $1.75 billion had already been committed since the campaign quietly began in 2024, putting it past the halfway point toward its goal.
Table of Contents
Michael J Fox: Michael J. Fox campaign focuses on faster Parkinson’s research
The campaign is the foundation’s first multi-year fundraising drive and is intended to support research across the development process, from early scientific discoveries to clinical testing and potential treatments.
Foundation officials said the funding will build on its existing research agenda and help move promising ideas forward more quickly.
“All Grit.
No Quit.” is designed around the idea that patients, researchers, donors, industry partners and policymakers need to work together to shorten the path from laboratory findings to meaningful improvements for people living with Parkinson’s.
The foundation said more than 276,000 donors have contributed to the campaign so far.
It also credited more than 13,000 grassroots Team Fox events and fundraisers, along with hundreds of planned-giving supporters, for helping build the campaign’s early momentum.
Foundation has funded more than $3 billion in research
The Michael J.
Fox Foundation was established in 2000, several years after Fox publicly disclosed his Parkinson’s diagnosis.
Fox was diagnosed with Parkinson’s disease in 1991 at age 29 and has since used his public profile to raise awareness, challenge stigma and push for greater research investment.
The foundation says it has directed more than $3 billion toward Parkinson’s research globally since its creation.
Its work includes funding clinical studies, supporting data-sharing efforts, helping recruit participants for trials and backing research into biomarkers that could improve diagnosis and treatment development.
The foundation said its programmes have contributed to the approval of 23 new drugs over the past decade, while 175 additional therapies are in clinical testing.
It also pointed to the discovery and validation of a Parkinson’s biomarker in 2023 as an example of the scientific progress it has helped support.
Fox receives major honours during busy September
The campaign announcement came during a month in which Fox received two major honours for his acting career and Parkinson’s advocacy.
On September 9, he received the 2026 Lasker-Bloomberg Public Service Award for empowering patients and accelerating Parkinson’s research.
The Lasker Foundation said Fox had helped raise the profile of Parkinson’s disease, reduce stigma and reshape the role of patients in medical research.
Fox was also presented with the Bob Hope Humanitarian Award during the 78th Emmy Awards ceremony on September 14.
The Television Academy said the award recognized his contributions to Parkinson’s research and advocacy.
Fox’s recent honours reflect a career that has increasingly combined entertainment, public service and medical philanthropy.
What the campaign means for Parkinson’s research
Parkinson’s disease is a progressive neurological condition that can affect movement, sleep, mood, thinking, digestion and other systems in the body.
Current treatments can help manage symptoms, but they do not stop or reverse the underlying progression of the disease.
The foundation said approximately six million people worldwide are living with Parkinson’s disease and warned that the number is expected to grow substantially in the coming decades.
Its campaign is therefore focused not only on developing better symptom control, but also on finding therapies that could slow, stop or prevent disease progression.
Foundation officials said the campaign will support work across multiple research areas at the same time rather than waiting for one scientific approach to succeed before backing another.
That strategy could help researchers investigate disease biology, improve early detection and advance potential treatments in parallel.
What happens next
The foundation is expected to continue raising money through major donors, corporate partnerships, grassroots events and individual contributions.
Campaign funds will be directed through the foundation’s research and partnership programmes, with priorities shaped by its scientific agenda and the needs identified by people living with Parkinson’s.
Fox has said the recognition and fundraising momentum belong to the wider Parkinson’s community, including patients, families, scientists and advocates.
The foundation’s stated goal is to use the campaign to move Parkinson’s research closer to therapies that offer more than temporary symptom relief.
Frequently Asked Questions
What is Michael J. Fox’s new Parkinson’s campaign?
It is a multi-year $2.5-billion fundraising initiative called “All Grit. No Quit.” that aims to accelerate Parkinson’s research, treatment development and the search for a cure.
How much has the Michael J. Fox Foundation already raised?
The foundation said more than $1.75 billion had been committed to the campaign since its quiet launch in 2024.
How much Parkinson’s research has the foundation funded?
The foundation says it has funded more than $3 billion in Parkinson’s research globally since it was established in 2000.
What major awards did Michael J. Fox receive in September 2026?
Fox received the 2026 Lasker-Bloomberg Public Service Award on September 9 and the Bob Hope Humanitarian Award at the 78th Emmy Awards on September 14.
Does Parkinson’s disease currently have a cure?
No. Existing treatments can manage symptoms, but there is currently no treatment that stops or reverses the progression of Parkinson’s disease.
Fact-Checked: Key dates, campaign figures, award details and research claims were checked against official Michael J. Fox Foundation, Lasker Foundation and Television Academy information.
Disclaimer: This article discusses Parkinson’s research and does not provide medical advice or treatment recommendations.